NOVN Related Analyst Ratings
-
Caris Downgrades Noven Pharma (NOVN) to Neutral
-
Ladenburg Thalmann Downgrades Noven Pharmaceuticals (NOVN) to Neutral
-
Jefferies & Co Upgrades Noven Pharmaceuticals (NOVN) to Hold
-
Ladenburg Thalmann Starts Noven Pharmaceuticals (NOVN) at Buy
-
Jefferies Downgrades Noven Pharmaceuticals (NOVN) to Underperform
-
Matrix USA Rating Changes 6/2
-
Matrix USA Rating Changes 5/21
-
Roth Capital Initiates Coverage on Noven Pharmaceuticals (NOVN) with a Buy
-
Deutsche Bank Says Noven (NOVN) Delayed 10K Filing 'Not Significant'
-
Soleil Securities downgrades Noven Pharmaceuticals (NOVN) to Sell
-
West Coast Asset Mgmt Present Its 50% Upside Idea--Noven Pharmaceuticals (NOVN)
-
West Coast Asset Mgmt Present Its Best Idea--Noven Pharmaceuticals (NOVN)
-
Raymond James upgrades Noven Pharmaceuticals (NOVN) to Strong Buy
-
Matrix USA Rating Changes 10/10
-
Robert Baird downgrades Noven Pharmaceuticals (NOVN) to Neutral
-
Soleil Securities Group Upgrades Noven Pharma (NOVN) to Hold
-
Deutsche Bank downgrades Noven Pharma (NOVN) to Hold
-
Baird Starts Noven Pharmaceuticals (NOVN) at Outperform
-
Jefferies downgrades Noven Pharmaceuticals Inc. (NOVN) to Hold
-
Oppenheimer downgrades Noven Pharmaceuticals (NOVN) to Neutral
-
Jefferies upgrades Noven Pharmaceuticals (NOVN) to Buy
-
Oppenheimer Started NOVN at Buy
-
NOVN started at Buy at Soleil Securities
Back to NOVN Stock Lookup
